NCT05211193View on ClinicalTrials.gov

Open Label Study to Evaluate the Efficacy of the Home Based Electrical Transcutaneous URIS I in the Treatment of Overactive Bladder (OAB).

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

January 8, 2020

Primary Completion Date

April 28, 2020

Study Completion Date

November 2, 2020

Conditions
Overactive Bladder (OAB)Failed Any OAB Pharmacotherapy
Interventions
DEVICE

eTNM delivered by URIS I nerve stimulation device

eTNM delivered by URIS I nerve stimulation device, self administered in the subject's home for 30 minutes per day, for a minimum of 34 therapy session between day 1-42.

Trial Locations (1)

261 01

MUDr. Michal Rejchrt, Příbram

All Listed Sponsors
lead

Stimvia s.r.o.

INDUSTRY

NCT05211193 - Open Label Study to Evaluate the Efficacy of the Home Based Electrical Transcutaneous URIS I in the Treatment of Overactive Bladder (OAB). | Biotech Hunter | Biotech Hunter